Fresenius Medical Care AG & Co KGaA
XETRA:FME
Operating Margin
Fresenius Medical Care AG & Co KGaA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
15B EUR |
7%
|
|
US |
C
|
Cigna Group
XMUN:CGN
|
74.9B EUR |
4%
|
|
US |
![]() |
Cigna Corp
NYSE:CI
|
85.3B USD |
4%
|
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
76.8B USD |
3%
|
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
30B EUR |
7%
|
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
24.3B EUR |
9%
|
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
20.3B USD |
9%
|
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
19.2B USD |
14%
|
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
12.3B USD |
6%
|
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
10.7B USD |
15%
|
|
US |
![]() |
Chemed Corp
NYSE:CHE
|
8.3B USD |
17%
|
Fresenius Medical Care AG & Co KGaA
Glance View
Fresenius Medical Care AG & Co KGaA, articulating a saga of innovation and resilience, stands at the global forefront of dialysis care. Born out of a convergence of medical expertise and humanitarian ambition, the company caters to individuals battling chronic kidney disease. It operates through an intricate network of dialysis clinics and manufacturing facilities spread across continents. These clinics are the lifeline for many, transforming what is essentially a life-threatening condition into a manageable routine. The process is remarkable: patients are connected to dialysis machines, many of which are crafted by Fresenius itself. These machines emulate the essential functions of kidneys by filtering and purifying blood, a process pivotal for sustaining life in those with kidney failure. The dual avenues of Fresenius Medical Care's revenue generation create a unique synergy driving the company's success. One arm of its business involves providing essential dialysis treatments through its expansive clinic network, offering healthcare services directly to patients worldwide. The other arm engages in the production and sale of dialysis products, encompassing everything from dialysis machines to a wide range of associated medical supplies. Hospitals and other healthcare providers across the globe depend on these products, further broadening Fresenius's impact and revenue streams. This symbiotic integration of services and products not only reinforces its market leadership but also aligns the company's growth with advancements in patient outcomes and healthcare technology.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Fresenius Medical Care AG & Co KGaA's most recent financial statements, the company has Operating Margin of 6.8%.